1. Home
  2. MATH vs IMRX Comparison

MATH vs IMRX Comparison

Compare MATH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • IMRX
  • Stock Information
  • Founded
  • MATH 2015
  • IMRX 2008
  • Country
  • MATH Hong Kong
  • IMRX United States
  • Employees
  • MATH N/A
  • IMRX 54
  • Industry
  • MATH Finance/Investors Services
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATH Finance
  • IMRX Health Care
  • Exchange
  • MATH Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • MATH 60.8M
  • IMRX 145.7M
  • IPO Year
  • MATH N/A
  • IMRX 2021
  • Fundamental
  • Price
  • MATH $3.60
  • IMRX $4.24
  • Analyst Decision
  • MATH
  • IMRX Strong Buy
  • Analyst Count
  • MATH 0
  • IMRX 4
  • Target Price
  • MATH N/A
  • IMRX $13.25
  • AVG Volume (30 Days)
  • MATH 197.9K
  • IMRX 3.1M
  • Earning Date
  • MATH 08-26-2025
  • IMRX 08-05-2025
  • Dividend Yield
  • MATH N/A
  • IMRX N/A
  • EPS Growth
  • MATH N/A
  • IMRX N/A
  • EPS
  • MATH 0.17
  • IMRX N/A
  • Revenue
  • MATH $31,399,049.00
  • IMRX N/A
  • Revenue This Year
  • MATH N/A
  • IMRX N/A
  • Revenue Next Year
  • MATH N/A
  • IMRX N/A
  • P/E Ratio
  • MATH $22.72
  • IMRX N/A
  • Revenue Growth
  • MATH 291.58
  • IMRX N/A
  • 52 Week Low
  • MATH $0.80
  • IMRX $1.00
  • 52 Week High
  • MATH $4.17
  • IMRX $4.60
  • Technical
  • Relative Strength Index (RSI)
  • MATH 61.32
  • IMRX 77.22
  • Support Level
  • MATH $3.55
  • IMRX $3.31
  • Resistance Level
  • MATH $3.97
  • IMRX $4.60
  • Average True Range (ATR)
  • MATH 0.32
  • IMRX 0.43
  • MACD
  • MATH 0.03
  • IMRX 0.12
  • Stochastic Oscillator
  • MATH 83.49
  • IMRX 96.10

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: